In this issue:
- A progressive approach to managing atrial fibrillation
- Combination treatment with GLP-1 receptor agonists and SGLT-2 inhibitors reduces CV events
- Interacting safely with low-dose methotrexate
- Effectiveness of continuous glucose monitoring on glycaemic control in T2D
- Assessing, communicating and managing cardiovascular disease risk
- PDE-5 inhibitors and cardiac health guidelines
- Physician associates in New Zealand primary health care
- Seasonal influenza vaccinations
- Restrictions on funded GLP-1 receptor agonists
- COPD single inhaler triple therapy to be funded
- Shingles vaccine funded for select immunocompromised people
- HIV combination treatment funded
- Niraparib funded for ovarian cancer
- Funding proposal for T1D
- Monitoring communication: Calcium channel blockers and new-onset eczema
- ACC rongoā Māori YouTube channel
- Your Work Counts diary study
- Should primary care proactively take up AI?
- ADHD treatment in Aotearoa
Please login below to download this issue (PDF)